Dr Reddys Laboratories Cash Flow Statement (2009-2023) | RDY

Cash Flow Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Sep2014 Dec2014 Jun2015 Sep2015 Dec2015 Mar2016 Sep2016 Dec2016 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Mar2020 Jun2020 Sep2020 Mar2021 Jun2021 Sep2022 Dec2022 Mar2023 Jun2023
Operating Activities
Net Income (Quarter)
0.09B0.02B0.05B0.04B0.06B0.07B0.07B0.06B0.14B0.11B0.07B0.08B0.10B-0.11B0.08B0.13B152.000.12B0.17B0.17B
Depreciation and Depletion (Quarter)
0.03B0.03B0.03B
Share-based Compensation (Quarter)
Deferred Taxes (Quarter)
Cash from Discontinued Operations (Quarter)
2.71B5.23B6.71B7.52B
Asset Writedowns and Impairment (Quarter)
0.05B0.18B0.01B0.18B0.01B2.000.01B0.00B
Non-cash Items (Quarter)
Cash from Operations (Quarter)
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
0.00B0.01B
Amortizatization of Intangibles (Quarter)
0.01B0.01B0.02B
Depreciation & Amortization (CF) (Quarter)
0.03B0.03B0.03B
Change in Working Capital
Change in Receivables (Quarter)
Change in Inventory (Quarter)
Change in Account Payables (Quarter)
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)
Divestments (Quarter)
-26.04B2.06B-5.23B-10.22B
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
Financing Activities
Cash from Financing Activities (Quarter)
19.52B-3.52B-1.94B2.24B-1.67B
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
-3.81B3.77B-0.46B-0.46B1.81B
Free Cash Flow (Quarter)
Net Cash Flow (Quarter)
19.52B-3.52B-1.94B2.24B-1.67B